Prediabetes affects an estimated 115 million American adults, and many of them do not know it. The connection between prediabetic glucose levels and poor sleep is well supported by research: sleep disruption both results from and accelerates prediabetic metabolic changes.
Understanding this connection matters for long-term brain health, cognitive protection, and maintaining glucose control before it progresses to type 2 diabetes. When glucose regulation enters the prediabetic range, sleep architecture changes are already measurable — and when sleep quality improves, glucose regulation can respond in kind.
This article covers how prediabetes changes sleep architecture and how sleep quality affects prediabetic glucose levels. For the broader metabolic picture, see Metabolic Sleep Disruption: How Metabolic Impairment Fragments Sleep and How to Recognize It.
How Does Prediabetes Change Sleep Architecture?
A 2024 study from the Baependi Heart Study (Chen DM et al.) conducted at-home polysomnography in 1,074 participants and compared sleep architecture across glycemic categories. Adults with prediabetes had 5.9 fewer minutes of REM sleep per night (95% CI: -10.5 to -1.3) compared to those with normal glucose, after adjusting for age, sex, BMI, and apnea-hypopnea index. Adults with diabetes showed a larger reduction of 6.7 fewer minutes of REM sleep and 13.7 fewer minutes of total sleep time.
These findings held after excluding participants with moderate-to-severe sleep apnea (AHI >=30), showing that the REM reduction is not an artifact of obstructive sleep apnea. The architecture changes are present at the prediabetes stage — before glucose levels reach the diabetic threshold.
The REM reductions observed here are relevant to cognitive health. REM sleep supports memory consolidation, emotional regulation, and overnight learning. A nightly deficit of nearly 6 minutes, accumulated over months and years, represents a cumulative reduction in the sleep stage responsible for these functions.
A separate 2019 study (Iyegha et al.) examined 155 adults and found that 62% of the prediabetes group reported poor sleep, compared to 46% of those with normal glucose. C-reactive protein (CRP) — a marker of inflammation — was nearly double in the prediabetes group (0.37 vs. 0.18 mg/L). Sleep disturbance independently predicted CRP levels (beta = 0.20, p = 0.04) after adjusting for age, sex, and BMI.
This suggests that inflammation may be the mediating pathway. In this cohort, the direct association between sleep quality and glucose measures did not remain significant after adjusting for covariates — but the sleep-inflammation connection did. Prediabetes may degrade sleep quality in part through the inflammatory burden it produces.
The architecture changes can be measurable before subjective complaints appear. A person with prediabetic glucose levels may still report sleeping “fine” while accumulating a nightly REM deficit.
Can Short Sleep Push You from Prediabetes to Diabetes?
A 2009 randomized crossover study (Nedeltcheva et al.) enrolled 11 healthy adults in two 14-day inpatient conditions: 8.5-hour versus 5.5-hour bedtimes, under sedentary conditions with ad libitum food intake designed to approximate a modern Western lifestyle. Sleep was reduced by 122 minutes per day in the restricted condition.
Oral glucose tolerance testing showed that 2-hour glucose values rose from 132 mg/dL to 144 mg/dL in the sleep-restricted condition (p < 0.01) -- crossing into the impaired glucose tolerance range for many participants. Insulin sensitivity dropped (3.3 vs. 4.0, p < 0.03). Twenty-four-hour epinephrine levels and nighttime norepinephrine were modestly elevated, pointing to sympathetic nervous activation as a contributing mechanism.
This study design — sedentary behavior, excess calories, and short sleep — represents the combination that drives prediabetes progression in everyday life and reflects how many people live.
A 2023 prospective analysis from the UK Biobank (Wang B et al.) followed 358,805 participants for a median of 12.4 years and recorded 29,663 cardiovascular events. The researchers constructed a composite sleep score incorporating chronotype, duration, insomnia, snoring, and daytime sleepiness, then examined how this score interacted with glucose tolerance.
The interaction was significant (p = 0.002). Each additional point of worsening sleep score was associated with a 7% increase in cardiovascular risk in people with normal glucose, 11% in those with prediabetes, and 13% in those with diabetes. Poor sleep was attributable to 14.2% of cardiovascular cases in the normal glucose group, 19.5% in prediabetes, and 25.1% in diabetes.
This gradient matters: prediabetes is associated with a greater cardiovascular burden from poor sleep compared to normal glucose. The same degree of sleep disruption is linked to a larger metabolic and cardiovascular consequence when glucose regulation is already impaired.
A 2025 meta-analysis (Liu et al.) synthesized 73 studies comprising over 1.4 million participants. Short sleep (7 hours or fewer) was associated with an 18% higher risk of type 2 diabetes (OR = 1.18, 95% CI: 1.13-1.23). Poor sleep quality carried a 50% higher risk (OR = 1.50, 95% CI: 1.30-1.72). Evening chronotype was associated with a 59% increased risk (OR = 1.59, 95% CI: 1.18-2.13).
Risk was highest in people combining poor sleep quality with long nighttime sleep duration (OR = 2.15, 95% CI: 1.19-3.91) — suggesting that multiple sleep impairments compound metabolic risk.
Can Improving Sleep Reverse Prediabetic Glucose Levels?
A 2024 randomized controlled trial (Groeneveld et al.) assigned 57 adults with type 2 diabetes and insomnia to six sessions of online cognitive behavioral therapy for insomnia (CBT-I) or care as usual, with outcomes assessed at 3 and 6 months.
CBT-I reduced insomnia severity scores by 1.37 points relative to the control group and produced measurable improvements in depressive markers. Among participants who completed the full program, HbA1c trended downward by 2.10 mmol/mol (95% CI: -4.83 to 0.63) and fasting glucose declined by 0.39 mmol/L (95% CI: -1.19 to 0.42). Neither glycemic outcome reached statistical significance.
The 50% dropout rate limits the statistical power of this trial. Only half the participants completed the full CBT-I program — a feasibility challenge common in online behavioral approaches for people managing chronic conditions. The glycemic trends were in the expected direction, but a larger trial with higher adherence would be needed to establish whether sleep improvement alone moves glucose numbers.
The mechanism for reversibility has experimental support. Laboratory studies have shown that short-term sleep restriction produces measurable increases in insulin resistance within one week (Buxton et al., 2010). Because these changes were experimentally induced by the sleep restriction itself, they are plausibly reversible when adequate sleep is restored — though direct reversal trials in prediabetic populations have not yet been completed.
Current evidence supports addressing sleep as part of prediabetes management, alongside diet and exercise. Because the relationship between sleep and glucose regulation is bidirectional, improving one can support the other. A large-scale trial demonstrating that sleep improvement alone reverses prediabetic HbA1c has not yet been completed.
Related Reading
- Metabolic Sleep Disruption: How Metabolic Impairment Fragments Sleep
- Can a Blood Sugar Drop Wake You Up at 3am?
- Why Do You Wake Up Hungry at 3am?
- Why Does Cortisol Spike at 3am and Wake You Up?
- Can a Calorie Deficit Cause Insomnia?
- Adrenal Fatigue and 3am Waking: What Is Actually Happening?
- Does Insulin Resistance Affect Sleep Quality?
- Can a Continuous Glucose Monitor Show Why You Wake Up at 3am?
- Why Does Intermittent Fasting Disrupt Your Sleep?
- Does Keto Cause 3am Waking? What Happens to Blood Sugar When You Cut Carbs
- Does Visceral Fat Block Your Growth Hormone Pulses During Sleep?
- Does Your Blood Sugar Rise While You Sleep Even If You Don’t Have Diabetes?
- Does Fatty Liver Cause Sleep Problems?
- Does Gut Dysbiosis Cause the Blood Sugar Swings That Wake You at 3am?
- Can Eating Late Cause a Blood Sugar Crash That Wakes You at 3am?
References
Buxton, O. M., Pavlova, M., Reid, E. W., Wang, W., Simonson, D. C., & Adler, G. K. (2010). Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes, 59(9), 2126-2133. https://pubmed.ncbi.nlm.nih.gov/20585000/
Chen, D. M., Taporoski, T. P., Alexandria, S. J., Aaby, D. A., Beijamini, F., Krieger, J. E., von Schantz, M., Pereira, A. C., & Knutson, K. L. (2024). Altered sleep architecture in diabetes and prediabetes: findings from the Baependi Heart Study. Sleep, 47(1), zsad229. https://pubmed.ncbi.nlm.nih.gov/37658822/
Groeneveld, L., Beulens, J. W. J., Blom, M. T., van Straten, A., van der Zweerde, T., Elders, P. J. M., & Rutters, F. (2024). The effect of cognitive behavioral therapy for insomnia on sleep and glycemic outcomes in people with type 2 diabetes: A randomized controlled trial. Sleep Medicine, 120, 44-52. https://pubmed.ncbi.nlm.nih.gov/38878350/
Iyegha, I. D., Chieh, A. Y., Bryant, B. M., & Li, L. (2019). Associations between poor sleep and glucose intolerance in prediabetes. Psychoneuroendocrinology, 110, 104444. https://pubmed.ncbi.nlm.nih.gov/31546116/
Liu, H., Zhu, H., Lu, Q., Ye, W., Huang, T., Li, Y., Li, B., Wu, Y., Wang, P., Chen, T., Xu, J., & Ji, L. (2025). Sleep features and the risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Annals of Medicine, 57(1), 2447422. https://pubmed.ncbi.nlm.nih.gov/39748566/
Nedeltcheva, A. V., Kessler, L., Imperial, J., & Penev, P. D. (2009). Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. The Journal of Clinical Endocrinology and Metabolism, 94(9), 3242-3250. https://pubmed.ncbi.nlm.nih.gov/19567526/
Wang, B., Zhang, H., Sun, Y., Tan, X., Zhang, J., Wang, N., & Lu, Y. (2023). Association of sleep patterns and cardiovascular disease risk is modified by glucose tolerance status. Diabetes/Metabolism Research and Reviews, 39(6), e3642. https://pubmed.ncbi.nlm.nih.gov/37009685/
Written by Kat Fu, M.S., M.S. — Last reviewed: April 2026 — 7 references cited